142 related articles for article (PubMed ID: 28541099)
1. Cost-effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett's esophagus.
Filby A; Taylor M; Lipman G; Lovat L; Haidry R
J Comp Eff Res; 2017 Jul; 6(5):425-436. PubMed ID: 28541099
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom.
Pollit V; Graham D; Leonard C; Filby A; McMaster J; Mealing SJ; Lovat LB; Haidry RJ
Curr Med Res Opin; 2019 May; 35(5):805-815. PubMed ID: 30479169
[TBL] [Abstract][Full Text] [Related]
3. The cost effectiveness of radiofrequency ablation for Barrett's esophagus.
Hur C; Choi SE; Rubenstein JH; Kong CY; Nishioka NS; Provenzale DT; Inadomi JM
Gastroenterology; 2012 Sep; 143(3):567-575. PubMed ID: 22626608
[TBL] [Abstract][Full Text] [Related]
4. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.
Shaheen NJ; Inadomi JM; Overholt BF; Sharma P
Gut; 2004 Dec; 53(12):1736-44. PubMed ID: 15542506
[TBL] [Abstract][Full Text] [Related]
5. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
6. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
7. A cost-utility analysis of ablative therapy for Barrett's esophagus.
Inadomi JM; Somsouk M; Madanick RD; Thomas JP; Shaheen NJ
Gastroenterology; 2009 Jun; 136(7):2101-2114.e1-6. PubMed ID: 19272389
[TBL] [Abstract][Full Text] [Related]
8. A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus.
Boger PC; Turner D; Roderick P; Patel P
Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1332-42. PubMed ID: 21050235
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.
Gordon LG; Mayne GC; Hirst NG; Bright T; Whiteman DC; ; Watson DI
Gastrointest Endosc; 2014 Feb; 79(2):242-56.e6. PubMed ID: 24079411
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of endoscopic radiofrequency ablation for the treatment of dysplastic Barrett's esophagus in Spain.
Esteban JM; González-Carro P; Gornals JB; Collados C; Álvarez M; Pérez-Mitru A; Serip S
Rev Esp Enferm Dig; 2018 Mar; 110(3):145-154. PubMed ID: 29168641
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial).
Phoa KN; Rosmolen WD; Weusten BLAM; Bisschops R; Schoon EJ; Das S; Ragunath K; Fullarton G; DiPietro M; Ravi N; Tijssen JGP; Dijkgraaf MGW; Bergman JJGHM;
Gastrointest Endosc; 2017 Jul; 86(1):120-129.e2. PubMed ID: 27956164
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
[TBL] [Abstract][Full Text] [Related]
13. [Endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) in neoplastic Barrett's esophagus or Barrett early cancer is also economically superior to sole radical endoscopic resection].
Wilke M; Rathmayer M; Schenker M; Schepp W
Z Gastroenterol; 2016 May; 54(5):416-20. PubMed ID: 27171331
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Esophagectomy Versus Endoscopic Treatment for Esophageal High-grade Dysplasia.
Hu Y; Puri V; Shami VM; Stukenborg GJ; Kozower BD
Ann Surg; 2016 Apr; 263(4):719-26. PubMed ID: 26672723
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Vij R; Triadafilopoulos G; Owens DK; Kunz P; Sanders GD
Gastrointest Endosc; 2004 Nov; 60(5):739-56. PubMed ID: 15557950
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
[TBL] [Abstract][Full Text] [Related]
17. When to consider endoscopic ablation therapy for Barrett's esophagus.
Shaheen NJ; Frantz DJ
Curr Opin Gastroenterol; 2010 Jul; 26(4):361-6. PubMed ID: 20531183
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis.
Comay D; Blackhouse G; Goeree R; Armstrong D; Marshall JK
Can J Gastroenterol; 2007 Apr; 21(4):217-22. PubMed ID: 17431509
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
20. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
